These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9822689)

  • 41. Processive phosphorylation of p130Cas by Src depends on SH3-polyproline interactions.
    Pellicena P; Miller WT
    J Biol Chem; 2001 Jul; 276(30):28190-6. PubMed ID: 11389136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains.
    Fernandez-Ballester G; Blanes-Mira C; Serrano L
    J Mol Biol; 2004 Jan; 335(2):619-29. PubMed ID: 14672668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hck SH3 domain-dependent abrogation of Nef-induced class 1 MHC down-regulation.
    Chang AH; O'Shaughnessy MV; Jirik FR
    Eur J Immunol; 2001 Aug; 31(8):2382-7. PubMed ID: 11500821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef.
    Arold S; O'Brien R; Franken P; Strub MP; Hoh F; Dumas C; Ladbury JE
    Biochemistry; 1998 Oct; 37(42):14683-91. PubMed ID: 9778343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
    Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
    Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
    Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
    Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
    Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
    Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity.
    Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID
    Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.
    Hassaïne G; Courcoul M; Bessou G; Barthalay Y; Picard C; Olive D; Collette Y; Vigne R; Decroly E
    J Biol Chem; 2001 May; 276(20):16885-93. PubMed ID: 11278465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A different function for a critical tryptophan in c-Raf and Hck.
    McPherson RA; Taylor MM; Hershey ED; Sturgill TW
    Oncogene; 2000 Jul; 19(32):3616-22. PubMed ID: 10951567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry.
    Engen JR; Smithgall TE; Gmeiner WH; Smith DL
    Biochemistry; 1997 Nov; 36(47):14384-91. PubMed ID: 9398156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
    Chen S; O'Reilly LP; Smithgall TE; Engen JR
    J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SH2- and SH3-mediated interactions between focal adhesion kinase and Src.
    Thomas JW; Ellis B; Boerner RJ; Knight WB; White GC; Schaller MD
    J Biol Chem; 1998 Jan; 273(1):577-83. PubMed ID: 9417118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reading between the lines: SH3 recognition of an intact protein.
    Lim WA
    Structure; 1996 Jun; 4(6):657-9. PubMed ID: 8805558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.